Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $851,234 - $1.27 Million
-10,500 Reduced 66.88%
5,200 $422,000
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $2.04 Million - $3.33 Million
-20,000 Reduced 56.02%
15,700 $1.83 Million
Q2 2021

Aug 13, 2021

BUY
$141.6 - $179.06 $1.47 Million - $1.86 Million
10,400 Added 41.11%
35,700 $5.92 Million
Q1 2021

May 14, 2021

BUY
$132.81 - $182.18 $3.11 Million - $4.26 Million
23,400 Added 1231.58%
25,300 $3.53 Million
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $5.31 Million - $7.08 Million
-38,400 Reduced 95.29%
1,900 $329,000
Q3 2020

Nov 13, 2020

SELL
$114.09 - $145.51 $501,996 - $640,244
-4,400 Reduced 9.84%
40,300 $5.61 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $465,140 - $675,220
-5,200 Reduced 10.42%
44,700 $5.34 Million
Q1 2020

May 14, 2020

BUY
$70.23 - $144.31 $1.92 Million - $3.95 Million
27,400 Added 121.78%
49,900 $4.99 Million
Q4 2019

Feb 13, 2020

SELL
$76.41 - $117.54 $6.95 Million - $10.7 Million
-90,900 Reduced 80.16%
22,500 $2.65 Million
Q3 2019

Nov 08, 2019

SELL
$61.52 - $91.1 $98,432 - $145,760
-1,600 Reduced 1.39%
113,400 $9.75 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $307,612 - $355,047
5,300 Added 4.83%
115,000 $7.46 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $2.55 Million - $4.49 Million
71,700 Added 188.68%
109,700 $6.86 Million
Q4 2018

Feb 13, 2019

SELL
$35.43 - $56.29 $1.27 Million - $2.02 Million
-35,800 Reduced 48.51%
38,000 $1.48 Million
Q3 2018

Nov 13, 2018

BUY
$44.22 - $75.47 $3.26 Million - $5.57 Million
73,800 New
73,800 $4.21 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $162M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.